ISO 13485
The ISO 13485 certificate demonstrates the ability of Enagic®'s Osaka manufacturing facility to consistently meet quality and regulatory requirements, the same standard applied to medical device manufacturers worldwide.
Trust verified by independent bodies. International quality standards for our Kangen Water Ionisers, and patented innovation with clinical research for emGuarde.
The ISO 13485 certificate demonstrates the ability of Enagic®'s Osaka manufacturing facility to consistently meet quality and regulatory requirements, the same standard applied to medical device manufacturers worldwide.
ISO 9001 certifies that Enagic® consistently provides products and services that meet customer, statutory, and regulatory requirements, with a continual focus on improvement and satisfaction.
ISO 14001 provides assurance that Enagic®'s environmental impact is actively measured and improved, reflecting a commitment to responsible manufacturing across every step of production.
Issued by Japan's Ministry of Health, Labour and Welfare, this authorisation reflects the rigorous manufacturing standards that Kangen Water Ionisers are built and tested to.
The Enagic® 8-Point Business Model is trademarked by the Japan Patent Office: a transparent, trusted framework for all independent distributors worldwide.
Enagic® International is a member in good standing of America's Direct Selling Association, a prestigious membership held by fewer than 200 companies worldwide.
Enagic® Singapore is officially recognised under the Direct Selling Association of Singapore, reflecting our commitment to ethical, transparent business practices in the local market.
The emGuarde technology is protected under myIPO Patent No. MY-192775-A, independently registered and verifiable. Introduced in October 2023, it is the first radiation harmoniser of its kind in the world.
emGuarde is formally recognised by the Malaysian Government and has been exhibited at the Malaysia Export Exhibition Centre (MEEC), affirming its standing at an official national level in its country of origin.
Recognised at the International Invention, Innovation and Technology Exhibition (ITEX) in 2010 for emGuarde's foundational technology as a computer radiation reducer.
Awarded at the International Invention Innovation Competition in Canada (iCAN) in 2016 for reducing electromagnetic radiation from electrical appliances.
Recognised at the International Innovation and Invention Competition (IIIC) in 2017 for the technology's demonstrated ability to improve microcirculation blood flow from a remote distance.
FCC and CE certified by SGS, with verified zero interference to Wi-Fi or any telecommunication signal across the entire frequency spectrum. Ref: FCC VTMHY2304000668YEA/2023 · CE VTMHY2304000667YEA/2023.
Independent clinical studies in 2020 by Universiti Sains Malaysia (USM) and an Ophthalmology & Medical Aesthetic Center in Taiwan, examining emGuarde's impact on blood circulation, heart rate, blood pressure, and eyeball microcirculation.